Emerging oligonucleotides and gene editing therapies offer greater precision, long-term efficacy, and improved adherence in ...

Currently available treatments for IPF are limited to only two approved drugs that come with significant side-effects, ...

Nuravax Inc., a clinical-stage biopharmaceutical company developing active immunotherapies for neurodegenerative diseases, announced today that two oral presentations—the Phase 1 clinical results and ...

Bhat: With the rapidly advancing landscape of IBD treatments and the increasing complexities of the health care system, integrating clinical pharmacists into IBD care teams offers substantial benefits ...

Pompe's disease is a lysosomal storage disorder caused by a genetic deficiency of GAA. The disease is associated with severe ...

A new study published in the journal of BMC Pharmacology and Toxicology showed that both fenofibrate and curcumin effectively ...

Expanded screening using the Vaidya & Carey algorithm significantly improved primary aldosteronism detection in patients with ...

Earlier, it was thought that obese people have stronger bones due to more body weight. But, doctors say that according to ...

A clinical guidance from the American College of Cardiology Solution Set Oversight Committee states that pharmacotherapy may ...

There is increased risk for stroke among women experiencing homelessness and unstable housing who have cocaine and alcohol co-use.

Investigators studied whether changes in renal hyperfiltration status affects patient outcomes using a Korean population cohort of more than 4.5 million patients.

Adding genetic testing to clinical familial hypercholesterolemia screening improves risk assessment, prognosis and helps to guide targeted therapy.